1. Home
  2. BNTX vs GRAB Comparison

BNTX vs GRAB Comparison

Compare BNTX & GRAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$93.24

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Logo Grab Holdings Limited

GRAB

Grab Holdings Limited

HOLD

Current Price

$5.00

Market Cap

21.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTX
GRAB
Founded
2008
2012
Country
Germany
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
24.8B
21.1B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNTX
GRAB
Price
$93.24
$5.00
Analyst Decision
Buy
Buy
Analyst Count
11
4
Target Price
$137.40
$6.38
AVG Volume (30 Days)
1.4M
43.9M
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$3,698,814,972.00
$3,228,000,000.00
Revenue This Year
$2.36
$23.99
Revenue Next Year
N/A
$21.71
P/E Ratio
N/A
$244.90
Revenue Growth
3.70
20.18
52 Week Low
$81.20
$3.36
52 Week High
$129.27
$6.62

Technical Indicators

Market Signals
Indicator
BNTX
GRAB
Relative Strength Index (RSI) 37.39 38.99
Support Level $91.11 $4.85
Resistance Level $93.76 $5.27
Average True Range (ATR) 2.08 0.13
MACD -0.30 -0.01
Stochastic Oscillator 21.18 30.00

Price Performance

Historical Comparison
BNTX
GRAB

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

About GRAB Grab Holdings Limited

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

Share on Social Networks: